Also, the god of war game for 2690 company has added another layer of hedges for the expected incremental production in 2018 to help lock in returns and cash flows.
The S P 500 futures currently trade five points,.2, above fair value.
To identify relapsed or refractory FL and dlbcl patients with tumors bearing EZH2 mutations who may be candidates for enrollment in Epizyme's ongoing Phase 2 clinical trial.
7:03 am AcelRx reported key results from the Phase 3 IAP312 study of zalviso (sufentanil sublingual tablet system an investigational product candidate being developed for the management of moderate-to-severe acute pain ( acrx ) : Throughout the study in 320 enrolled patients,.2 of patients.4.79 Capital IQ Consensus Estimate.Operating Cash Flow was.8 million in the quarter compared.6 million in the same quarter last year."The in vivo data published in AAC confirm the potential of CD101 as a future treatment option for patients with IAC because of the extraordinary tissue penetration at the site of infection." said David Perlin,.0.02 two analyst estimate; sees Q3 revs of 30 mln.9:08 am Procter Gamble files proxy statement w/ SEC; 'expects to drive 2 to 3 organic sales growth in fiscal 2018 reaffirms expectations for core earnings per share growth of 5 to 7 ( PG ) : 9:07 am Bank of Princeton commences trading.
On a full-year basis, overall market conditions and the competitive landscape for 2017 are expected to be similar to 2016.
Upcoming Milestones: pdufa date of August 29, 2017 for the completion of the review of the BLA for Anti-Rabies IgG therapy.
The company's consolidated debt-to-capital ratio and net-debt-to-capital ratio were 30 percent and 25 percent, respectively.Anglo American plc ( ngloy ) announces the value of rough diamond sales (Global Sightholder Sales and Auction Sales) for De Beers' sixth sales cycle of 2017, amounting to 572 million.The Company plans to announce topline data in Q1 2018 and file a Biologics License Application BLA) next year.A handful of consumer names lag with L'Oreal, Danone, and Pernod Ricard shedding between.2 and.1.Net sales in Other were down as a result of softer sales in China.Dollar after hitting a 19-month high yesterday.The Company anticipates that the tax rate will be at the more normalized level of approximately 33 in the thirdquarter.